Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | -0.29% | 38.06 | 0.9% | $1107.43m | |
| JNJ | Johnson & Johnson | 0.14% | 148.21 | 0.7% | $820.15m | |
| MRK | Merck & Co., Inc. | -0.08% | 83.47 | 0.7% | $646.78m | |
| ABBV | AbbVie, Inc. | 0.42% | 95.08 | 1.9% | $619.40m | |
| BMY | Bristol-Myers Squibb Co. | -0.14% | 63.15 | 1.0% | $617.68m | |
| AZN | AstraZeneca Plc | -1.08% | 55.20 | 1.2% | $504.65m | |
| LLY | Eli Lilly & Co. | -0.25% | 150.09 | 1.1% | $396.64m | |
| NVS | Novartis AG | -0.84% | 84.65 | 0.2% | $154.29m | |
| GSK | GlaxoSmithKline Plc | -1.55% | 40.55 | 0.2% | $129.26m | |
| MIST | Milestone Pharmaceuticals, Inc. | -2.17% | 8.55 | 0.0% | $117.60m | |
| OPK | OPKO Health, Inc. | -1.13% | 4.80 | 11.2% | $113.10m | |
| NVO | Novo Nordisk A/S | -0.85% | 65.78 | 0.1% | $68.42m | |
| RGEN | Repligen Corp. | -1.62% | 143.89 | 7.1% | $65.57m | |
| IMRN | Immuron Ltd. | 9.27% | 11.08 | 0.0% | $54.00m | |
| SNY | Sanofi | -2.03% | 50.33 | 0.2% | $53.85m |
Company Profile
Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which develops novel therapeutic compounds. It develops complement immunotherapies for the treatment of complement-dependent autoimmune and inflammatory diseases through APL-2 product. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.